Molecular Reference Standards by Gene
Horizon Discovery specializes in the engineering of patient‐relevant isogenic somatic models of human genetic diseases (X‐MAN™; gene‐X, Mutant And Normal). Employing its proprietary homologous recombination‐based, precision genome editing platform (GENESIS™), Horizon applies this expertise to the field of companion diagnostics by developing isogenic ‘knock‐in’ and ‘knock‐out’ human cell‐based control materials.












